<DOC>
	<DOCNO>NCT00937547</DOCNO>
	<brief_summary>1 . Hypothesis : If high risk genotype human papillomavirus ( HPV ) cause cervical cancer worldwide , genotype associate cervical cancer Venezuela would type found country . 2 . Objectives : Primary objective : The objective investigation determine presence genotype HVP infection cervical intraepithelial neoplasia grade 2/3 ( CIN 2/3 ) , Stage I cervical epidermoid carcinoma cervical adenocarcinoma . Specific objective : To establish presence HPV cervical cancer patient Venezuela geographic distribution . To establish HPV type link cervical cancer Venezuela geographic distribution .</brief_summary>
	<brief_title>Human Papillomavirus Infection Virus Genotyping Uterine Cervix Cancer Venezuela</brief_title>
	<detailed_description>In Venezuela , cervical cancer second lead cause cancer mortality woman . In developed country , although first cause cancer mortality , occupy remarkable place neoplastic pathology ( Cannistra , 1996 ; Dey , 1998 ) . Human Papilloma Virus ( HPV ) involve development cervical cancer , specially oncogenic type 16 18 ( Koskela , 2000 ; Markowska , 1999 ) . To date , still unknown HPV type frequent Venezuela . Several study make country conclude HPV 16 predominant type cervical pathology ( Graterol 2006 , Correnti 1997 , Muñoz 2003 ) , perform HVP genotyping detect type involve patient cervical cancer . Neither establish HPV type frequently involve genital wart Venezuela . The goal investigation perform genotypification HPV cervical cancer cervical intraepithelial neoplasia 2 3 Venezuela determine type frequently relate disease country . 4 . STUDY DESIGN : 4.1 . Collection cervical sample : 1 . Previous ethic committee approval ( Instituto Venezolano de Investigaciones Cientificas Instituto de Oncología Luis Razetti ) , go collect paraffin block 300 patient histological diagnosis CIN 2-3 Stage I cervical cancer . The sample obtain archive Pathology Units follow medical center Venezuela : Instituto de Oncología Luis Razetti , Anatomía Patológica Universidad Central de Venezuela ( Caracas ) , Hospital Oncológico Pérez Carreño ( Valencia ) , Maracaibo , Barquisimeto , Ciudad Bolívar , Puerto La Cruz , Mérida Barinas . Inclusion criterion : 1 . Paraffin block CIN 2/3 , Stage I cervical cancer biopsy obtain 2001 2011 . 2 . Properly block identification order obtain personal clinical patient information . 4.2 . Molecular biology procedure : 1 . Histologically handle tissue : previous identification pathologic lesion describe inclusion criterion expert pathologist ( sample lesion without necrosis ) , paraffin block cut 5 7 µm slide new blade glove cut . It obtain 1 slide distribute follow : one sample send Laboratorio de Virología Molecular del Instituto Venezolano de Investigaciones Científicas ; remain sample kept evaluation necessary . Each slide place proper container identify serial number order preserve patient intimacy avoid bias result . 2 . Deparaffinisation describe Coombs 1999 . 3 . Tissue digestion , DNA extraction precipitation describe Gravitt 2000 . 4 . HPV genotyping detect INNOLiPA system . The result correlate clinical information .</detailed_description>
	<mesh_term>Infection</mesh_term>
	<mesh_term>Uterine Cervical Neoplasms</mesh_term>
	<mesh_term>Cervical Intraepithelial Neoplasia</mesh_term>
	<mesh_term>Papillomavirus Infections</mesh_term>
	<criteria>paraffin block 329 patient histologic diagnosis CIN 2 , CIN 3 Stage I cervical cancer .</criteria>
	<gender>Female</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2012</verification_date>
	<keyword>cervical cancer</keyword>
	<keyword>Human Papillomavirus Infection</keyword>
</DOC>